Trial Interactive’s configurable Study Start-Up solution accelerates site activation with process automation, obstacle mitigation, timeline projection, and simplified regulatory submission. Trial Interactive has increasingly been implemented by study teams seeking to activate sites faster and ensure the path to starting the study itself is continuous and simple through seamless eTMF integration.
Clinical Study Start-Up Highlights
Create Essential Documents and Submission Packages
Reveal Bottlenecks Throughout the Site Activation Process
Reduce Compliance Risks
Seamlessly Transition from SSU to eTMF
Reduce Cycle Times and Ultimately Start Recruiting Patients Faster
Get Insights and Alerts on Documents/Submission Progress
"We were looking for a way to conduct our 500-site global trial more efficiently. Trial Interactive's Study Start-Up and eTMF solution enhances transparency for both Regado and its partners, and allows us to run the study with as little paper as possible."
Raul P. Lima, Executive Director of Clinical Operations, Regado Biosciences
“At CTI approximately 80% of our studies meet or exceed enrollment expectations, despite the challenging patient populations we work in, which is due in part to our excellent pre-trial and start-up processes. With its automation and global document management capabilities, Trial Interactive helps us streamline our study management process while meeting regulatory requirements, allowing for remote inspections and even faster start-up timelines.”
